AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
2
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
3
Israeli fintech Morning acquired for $150 million by Italy's TeamSystem
4
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news

Teva

20 stories about Teva
קור שולץ מנכ"ל חברת טבע תרופות 23.8.20

What’s behind the timed resurgence of lawsuits against Teva?

28.08.20|Sophie Shulman
The Israeli pharmaceutical giant was hit with three legal blows over the course of a few days
מטוס F-16 של חיל האוויר האמריקאי

Which Israeli company will be upgrading F-16 jets and how many employees is Teva firing?

23.08.20|CTech
CTech Daily Roundup: These socialist millionaires make robots to clean the pools of the world's wealthy
מפעל טבע טק נאות חובב פיטורים

Teva firing 350 employees from Israeli production facility

23.08.20|CTech
Pharmaceutical giant says Teva-Tech plant in Ne'ot Hovav was spared in previous cutbacks but that efforts to get it back to profitability proved to be unsuccessful
קאר שולץ מנכל טבע

Teva neck-deep in legal trouble with no end in sight

20.08.20|Sophie Shulman
Each new court case is revealing that the company walked the grey line on its path to remarkable success
הקברניט F35 לוקהיד מרטין

How did Israelis secretly build up the UAE’s military capabilities and why is Teva in trouble?

18.08.20|CTech
CTech Daily Roundup: Report: Secret clause of Israel-UAE deal lifts U.S. embargo on sale of F-35s to the Gulf state
מושל ניו יורק אנדרו קואומו

Double trouble for Teva as NY State files charges on same day as DOJ

18.08.20|CTech
Governor Andrew M. Cuomo announced that the New York State Department of Financial Services has initiated administrative proceedings against Teva in connection with the Opioid Crisis
קור שולץ קאר שולץ מנכ"ל טבע מסיבת עיתונאים בורסה לניירות ערך

Teva stock plummets by double figures on back of U.S. government kickback lawsuit

18.08.20|CTech and Sophie Shulman
The Department of Justice accuses Israeli drugmaker of using kickbacks to boost sales of its multiple sclerosis drug Copaxone, as well as causing the submission of false claims to Medicare
Evgeny Edelnant

Amitai Pollak | AllCloud, Vice President of Sales, Business Applications, EMEA

09.07.20|James Spiro
Israeli cloud service provider AllCloud has appointed former CIO of international markets at Teva, Amitai Pollak, as its new Vice President of Sales, Business Applications for the EMEA region
מפעל חברת טבע הר חוצבים ירושלים

Who raised $175 million and how do you mess up a $2 billion takeover?

08.06.20|CTech
CTech Daily Roundup: Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa
מפעל טבע נתניה

Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa

08.06.20|Sophie Shulman
Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition
קאר שולץ מנכל טבע

Teva Will Become Less of a Mess, Says CEO Kåre Schultz

20.02.20|Sophie Shulman
Two years after he moved to Israel to head the struggling Israeli drugmaker, Schultz seems more optimistic
קור שולץ מנכ"ל טבע 9.11.19

The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO

19.02.20|Sophie Shulman
Teva’s stock fluctuation is not the result of wrongdoing regarding the U.S. opioid abuse epidemic, but rather something born of the creativity of lawyers, Kåre Schultz said Wednesday at the company’s annual press conference in Tel Aviv
מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%
קור שולץ מנכ"ל טבע 9.11.19

Teva’s Small Print Gives Rise to Optimism

13.02.20|Sophie Shulman
The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
קור שולץ מנכ"ל טבע 9.11.19

Teva Receives FDA Approval for Migraine Autoinjector

29.01.20|Sophie Shulman
Teva’s anti-migraine injection was approved in late 2018 but struggled to establish a market share due to both Amgen and Eli Lilly offering a similar drug with an autoinjector
קור שולץ מנכ"ל טבע 9.11.19

Teva Fights Muddy Reputation With Positive Report

23.01.20|Sophie Shulman
Calcalist obtained a report commissioned by the Israeli drugmaker that details its economic contribution to the countries in which it operates
רופא מומחה קופת חולים קופות חולים מחלה

Premature Ejaculation: There’s an App, and a Patch, For That

01.12.19|Navit Zomer and Adi Pick
Virility develops a single-use electrified skin patch that, when placed on the perineum, can delay premature ejaculation by delivering neuromuscular stimulation
קור שולץ מנכ"ל טבע 9.11.19

Teva Faces U.S. Criminal Probe on Opioid-Related Distribution, Report Says

27.11.19|CTech
The Israeli drugmaker is one of six companies to receive subpoenas from federal investigators, the Wall Street Journal reported Tuesday
מטה חברת טבע תרופות

Teva in Talks With U.S. DoJ to End Price-Fixing Probe, Report Says

26.11.19|CTech
The Israeli drugmaker, along with several other companies investigated in the matter, have been holding talks on the subject for the past six months, Bloomberg reported
קור שולץ מנכ"ל טבע 9.11.19

Teva Raises $2.1 Billion in Debt Tender Offer

20.11.19|Sophie Shulman
Teva originally aimed to raise $1.5 billion, to redeem previous debentures it raised to finance the $40.5 billion acquisition of Actavis in 2016
Previous ArticlesMore Articles